$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
乙型肝炎治疗现状及最新研发进展
2025-10-19 11:44:20
Check Details
替诺福韦酯预防乙肝母婴传播
2025-10-19 11:44:20
Check Details
替诺福韦对于慢性乙肝炎患者的疗效和安全性xa0
2025-10-19 11:44:20
Check Details
乙肝攻略之“双蛋”假期如何公布乙肝病情
2025-10-19 11:44:20
Check Details
乙肝患者替诺福韦治疗后肝癌风险下降
2025-10-19 11:44:20
Check Details
细胞因子抗乙肝病毒治疗
2025-10-19 11:44:20
Check Details
病毒载量低的乙肝患者肝癌的风险也不小
2025-10-19 11:44:20
Check Details
乙型肝炎病毒和肝癌
2025-10-19 11:44:20
Check Details
替诺福韦可减少或逆转肝纤维化肝硬化
2025-10-19 11:44:20
Check Details
替诺福韦可使纤维化和肝硬化消退
2025-10-19 11:44:20
Check Details
在研新药可击碎乙肝病毒
2025-10-19 11:44:20
Check Details
慢性乙肝患者肝纤维化的临床预测指标
2025-10-19 11:44:20
Check Details
1
2
...
98
99
100
101
102
103
104
...
504
505
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Is defibrotide included in medical insurance?
2
When was defibrinoside launched on the market?
3
Will defibrination be reimbursed by medical insurance?
4
What conditions is defibrinoside suitable for treating?
5
What is the therapeutic effect of defibrotide?
6
How should defibrinoside be used?
7
What is the effect of defibrotide?
8
Defibrinoside Detailed Instructions
9
What is the effect of defibrination?
10
How effective is defibrotide in the treatment of hepatic veno-occlusive disease?
11
How effective is defibrotide in hepatic veno-occlusive disease?
12
What conditions can defibrotide treat?